HPCAL1 and Alzheimer disease: In addition, we found that VILIP3 may exert neuroprotective effects by modulating the Nrf2 pathway, but its specific molecular mechanism has not been elucidated, and further studies are needed to confirm the molecular properties of VILIP3 and its biological role in AD.